Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Fevzi Yalniz

University of Kentucky

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

10%

Immunology

30%

Treatment Outcome

20%

Hematology

20%

Cell Therapy

20%

Bleeding Disorders

10%

Cancer Biology

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles6

Matching-Adjusted Indirect Treatment Comparison to Assess the Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 Versus Belantamab Mafodotin in DREAMM-2, Selinexor-Dexamethasone in STORM Part 2, and Melphalan Flufenamide-Dexamethasone in HORIZON for the Treatment of Patients With Triple-Class Exposed Relapsed or Refractory Multiple Myeloma.

Article Link

Year:

2022

CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity.

Article Link

Year:

2021

Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid Leukemia.

Article Link

Year:

2021

Copy-number variations in adult patients with chronic immune thrombocytopenia.

Article Link

Year:

2020

Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?

Article Link

Year:

2020

Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes.

Article Link

Year:

2020

Collaborators2

Jason R. Westin

The University of Texas MD Anderson Cancer Center

UNITED STATES

Yago Nieto

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

How do I reach out?

Meet Kite AI